Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
08:00am, Thursday, 22'nd May 2025
Though oncology remains the largest therapeutic area in the pharmaceutical industry, the weight management field has caught fire in the past few years. Eli Lilly (LLY -3.04%) is one of the undisputed
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
04:37pm, Wednesday, 21'st May 2025
Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs
Lilly's Kisunla (donanemab) receives marketing authorization in Australia for the treatment of early symptomatic Alzheimer's disease
04:21pm, Wednesday, 21'st May 2025
The authorization in Australia is for adult patients who are Apolipoprotein E- ε 4 heterozygotes or non-carriers INDIANAPOLIS , May 21, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announc
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
01:12pm, Monday, 19'th May 2025
Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker last week abruptly announced that longtime CEO Lars Fruergaard Jor
Huge News for Eli Lilly Stock Investors!
05:40am, Sunday, 18'th May 2025
Eli Lilly (LLY 3.47%) has a strong pipeline of new medicines that could increase the stock price.
Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?
04:32am, Sunday, 18'th May 2025
Eli Lilly (LLY 3.47%) is gaining market share in a lucrative market that could be a catalyst for a stock price increase.
Eli Lilly: Obesity Drug Development To Go Beyond That Of Zepbound
04:22pm, Friday, 16'th May 2025
The company delivered 45% revenue growth in Q1 2025, driven by ZEPBOUND and MOUNJARO's strong performance in the obesity and diabetes markets. ZEPBOUND outperformed Novo Nordisk's WEGOVY in terms of w
Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in
03:18pm, Friday, 16'th May 2025
The global weight-loss drug market, once dominated by Novo Nordisk, is undergoing a dramatic transformation. On Friday, the Danish pharmaceutical giant announced it would replace its long-serving chie
BMO's Evan David Seigerman: Novo Nordisk CEO departure reflects disparity with Eli Lilly
12:29pm, Friday, 16'th May 2025
Evan David Seigerman, BMO Capital Markets head of healthcare research, joins CNBC's 'Money Movers' to discuss reactions to the departure of Novo Nordisk's CEO, what is means for the company's trajecto
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Friday, 16'th May 2025
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Eli Lilly and Company (LLY) BofA Securities 2025 Health Care Conference Call Transcript
02:51pm, Thursday, 15'th May 2025
Eli Lilly and Company (NYSE:LLY ) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Company Participants Lucas Montarce - CFO Mike Czapar - SVP, IR Conference Call Participants
2 Stocks That Plummeted During President Trump's First 100 Days in Office, and Where They Could Be Headed
04:55am, Thursday, 15'th May 2025
President Donald Trump's first 100 days in office occurred between Monday, Jan. 20, and Tuesday, April 29. During this period, the S&P 500 (^GSPC 0.10%) and Nasdaq Composite (^IXIC 0.72%) dropped by 7
Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?
09:55am, Wednesday, 14'th May 2025
Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid growth prospects.
PFE vs. LLY: Which Stock Is the Better Value Option?
12:45pm, Tuesday, 13'th May 2025
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Eli Lilly (LLY). But which of these two companies is the best option for those
Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order.
11:18am, Tuesday, 13'th May 2025
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.
